Use of the lipoxin receptor, fprl1, as a tool for...

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/50 (2006.01)

Patent

CA 2544983

Disclosed herein are compounds that selectively activate the FPRL1 receptor. Further disclosed are methods of alleviating inflammatory responses by regulating key steps in leukocyte trafficking and preventing neutrophil- mediated tissue damage by administering to a subject a therapeutically effective amount of the compounds disclosed herein. In addition, methods of modulating, or specifically agonizing, the FPRL1 receptor by administering an effective amount of the compounds disclosed herein are provided.

L'invention concerne des composés qui activent de manière sélective le récepteur FPRL1. L'invention concerne également des procédés destinés à soulager des réactions inflammatoires par régulation d'étapes clés dans le commerce illicite de leucocytes et dans la prévention de dommages tissulaires induits par des neutrophiles par administration à un sujet d'une quantité efficace sur le plan thérapeutique des composés de cette invention. En outre, cette invention concerne des procédés de modulation ou de production d'une action agoniste spécifique du récepteur FPRL1 par administration d'une quantité efficace des composés susmentionnés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of the lipoxin receptor, fprl1, as a tool for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of the lipoxin receptor, fprl1, as a tool for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of the lipoxin receptor, fprl1, as a tool for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1933020

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.